HK1042654A1 - Neuropathy improvers containing nitrogenous compounds as the active ingredient - Google Patents
Neuropathy improvers containing nitrogenous compounds as the active ingredientInfo
- Publication number
- HK1042654A1 HK1042654A1 HK02104447A HK02104447A HK1042654A1 HK 1042654 A1 HK1042654 A1 HK 1042654A1 HK 02104447 A HK02104447 A HK 02104447A HK 02104447 A HK02104447 A HK 02104447A HK 1042654 A1 HK1042654 A1 HK 1042654A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- groups
- hydrogen atoms
- single bonds
- active ingredient
- hydrocarbon groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/72—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/22—All rings being cycloaliphatic the ring system containing eight carbon atoms, e.g. pentalene
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
A compound represented by the Formula below, and an agent for the remedy of neural damage having the said compound as the active ingredient. <CHEM> ÄHere, G represents G1 shown below <CHEM> R<4> represents, hydrogen atoms and acyl groups, W represents single bonds and alkylenes, m represents 0 or 1, R<5> and R<6> represent hydrogen atoms, aliphatic hydrocarbon groups, alicyclic hydrocarbon groups, aromatic hydrocarbon groups and heterocyclic groups, and R<7> represents hydrogen atoms, acyl groups and alkoxycarbonyl groups. A<2> represents, single bonds, -O-, -NR<3>-, and -S(=O)n-, A<1> and A<3>represent single bonds, aliphatic hydrocarbon groups, alicyclic hydrocarbon groups, heterocyclic groups and phenylene groups, and A<4> represents single bonds, carbonyl groups and aliphatic hydrocarbon groups. R<1> and R<2> represent hydrogen atoms, alkyl groups, cycloalkyl groups, phenyl groups and heterocyclic groups. The previously mentioned functional groups may be substituted.Ü
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22225999 | 1999-08-05 | ||
JP22226099 | 1999-08-05 | ||
PCT/JP2000/005287 WO2001010433A1 (en) | 1999-08-05 | 2000-08-07 | Neuropathy improvers containing nitrogenous compounds as the active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1042654A1 true HK1042654A1 (en) | 2002-08-23 |
HK1042654B HK1042654B (en) | 2006-01-06 |
Family
ID=26524784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02104447.9A HK1042654B (en) | 1999-08-05 | 2002-06-14 | Neuropathy improvers containing nitrogenous compounds as the active ingredient |
Country Status (12)
Country | Link |
---|---|
US (1) | US7071359B1 (en) |
EP (1) | EP1201235B1 (en) |
KR (1) | KR20020016938A (en) |
CN (1) | CN1377263A (en) |
AT (1) | ATE306256T1 (en) |
AU (1) | AU782869B2 (en) |
BR (1) | BR0012907A (en) |
CA (1) | CA2382759A1 (en) |
DE (1) | DE60023144T2 (en) |
HK (1) | HK1042654B (en) |
MX (1) | MXPA02001240A (en) |
WO (1) | WO2001010433A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2597616A1 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE266102C (en) | ||||
MX4813E (en) | 1976-06-01 | 1982-10-19 | Upjohn Co | PROCEDURE FOR PREPARING ANALOGS OF PROSTAGLANDINAS |
US4171447A (en) | 1976-12-30 | 1979-10-16 | The Upjohn Company | Tri-halo prostaglandin intermediates |
US4205178A (en) | 1976-12-30 | 1980-05-27 | The Upjohn Company | 6-Keto prostaglandin E-type compounds |
US4124601A (en) | 1976-12-30 | 1978-11-07 | The Upjohn Company | Certain 5-halo-6,9α-epoxy-14-bromo(or chloro)-PGF1 compounds |
AU511711B2 (en) | 1976-12-30 | 1980-09-04 | Upjohn Company, The | 6-Oxo and 5, 6-Dihalo prostaglandin analogues |
US4166903A (en) | 1977-07-14 | 1979-09-04 | The Upjohn Company | 5-Hydroxy-PGI1 pyrrolidylamides |
US4191822A (en) | 1977-07-14 | 1980-03-04 | The Upjohn Company | 5-Hydroxy-PGI1 compounds |
US4167624A (en) | 1977-07-14 | 1979-09-11 | The Upjohn Company | 5-Hydroxy-PGI1 pyrrolinylamides |
US4174441A (en) | 1977-07-14 | 1979-11-13 | The Upjohn Company | Pyran analogs of 5-hydroxy-PGI1 |
US4170703A (en) | 1977-07-14 | 1979-10-09 | The Upjohn Company | 5-Hydroxy-PGI1 morpholinylamides |
US4110532A (en) | 1977-07-14 | 1978-08-29 | The Upjohn Company | 5-Hydroxy-PGI1 compounds |
US4226984A (en) * | 1977-08-03 | 1980-10-07 | The Upjohn Company | 2-Decarboxy-2-aminomethyl-trans-4,5-didehydro-PGI1 compounds |
US4128713A (en) | 1977-12-15 | 1978-12-05 | The Upjohn Company | 6,7-Didehydro-PGI1 compounds |
US4705806A (en) | 1978-02-13 | 1987-11-10 | Morton Jr Douglas R | Prostacyclin analogs |
JPS5931510B2 (en) | 1979-09-03 | 1984-08-02 | 東レ株式会社 | 5,6,7-trinor-4,8-inter-m-phenylene PGI↓2 derivative |
JPS5732277A (en) * | 1980-08-05 | 1982-02-20 | Toray Ind Inc | 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative |
DE3048906A1 (en) | 1980-12-19 | 1982-07-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | NEW CARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
DE3104044A1 (en) | 1981-02-02 | 1982-08-26 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | NEW PROSTACYCLIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
JPS57144276A (en) | 1981-03-03 | 1982-09-06 | Toray Ind Inc | 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative |
DE3306125A1 (en) | 1983-02-18 | 1984-08-23 | Schering AG, 1000 Berlin und 4709 Bergkamen | Novel carbacyclins, process for their preparation and their use as medicaments |
DE3209702A1 (en) | 1982-03-12 | 1983-09-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Novel carbacyclins, process for their preparation and their use as medicaments |
GR77976B (en) | 1982-03-12 | 1984-09-25 | Schering Ag | |
JPS58164512A (en) | 1982-03-25 | 1983-09-29 | Ono Pharmaceut Co Ltd | Remedy for cell disorder containing prostaglandin analog compound as an active ingredient |
JPS58192821A (en) | 1982-04-30 | 1983-11-10 | Dainippon Pharmaceut Co Ltd | Remedy for anoxia of cranial nerve cells |
DE3315356A1 (en) | 1982-04-30 | 1983-11-17 | Ono Pharmaceutical Co. Ltd., Osaka | USE OF PROSTAGLANDINE ANALOGS |
DE3225287A1 (en) | 1982-07-02 | 1984-01-05 | Schering AG, 1000 Berlin und 4709 Bergkamen | NEW CARBACYCLINAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
DE3226550A1 (en) | 1982-07-13 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | NEW CARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
JPS59141536A (en) | 1983-02-01 | 1984-08-14 | Sumitomo Chem Co Ltd | Novel bicyclooctane derivative and preparation thereof |
JPS59210044A (en) | 1983-05-13 | 1984-11-28 | Teijin Ltd | Prostacycline compound, its preparation and pharmacological composition containing said compound as active component |
GB8429545D0 (en) | 1984-11-22 | 1985-01-03 | May & Baker Ltd | Compositions of matter |
JPS61197518A (en) | 1985-02-27 | 1986-09-01 | Teijin Ltd | Medicine for circulatory organ containing prostacycline compound as active component |
JPH0680028B2 (en) * | 1985-09-18 | 1994-10-12 | 財団法人相模中央化学研究所 | Prostacyclins and drugs containing them |
JPS63141927A (en) | 1986-12-04 | 1988-06-14 | Sagami Chem Res Center | Ameliorant for circulation containing prostacyclin analog as active ingredient |
EP0365678B1 (en) | 1987-10-16 | 1994-01-05 | Toray Industries, Inc. | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF |
EP0330025B1 (en) | 1988-02-23 | 1994-10-12 | Teijin Limited | Antidiabetic composition comprising isocarbacyclin derivative |
JP2608135B2 (en) | 1989-03-31 | 1997-05-07 | 科研製薬株式会社 | Diabetic neuropathy treatment |
JP2820504B2 (en) | 1990-05-21 | 1998-11-05 | 帝人株式会社 | Isocarbacycline derivative |
JP3250936B2 (en) | 1995-03-10 | 2002-01-28 | 科学技術振興事業団 | Isocarbacycline derivative |
JPH0967285A (en) * | 1995-09-01 | 1997-03-11 | Teijin Ltd | Isocarbacyclins |
JP3908306B2 (en) | 1996-10-01 | 2007-04-25 | 独立行政法人科学技術振興機構 | Isocarbacycline derivative |
WO1998041209A1 (en) | 1997-03-14 | 1998-09-24 | Toray Industries, Inc. | Protective agents for cells constituting nervous system |
JP2957148B2 (en) | 1997-06-17 | 1999-10-04 | 科学技術振興事業団 | 15-deoxy-isocarbacycline derivatives |
DE19739693A1 (en) | 1997-09-04 | 1999-03-11 | Schering Ag | Synergistic treatment of multiple sclerosis and other neurodegenerative disorders |
US6087395A (en) | 1997-10-21 | 2000-07-11 | Japan Science And Technology Corporation | Isocarbacyclin derivatives as apoptosis inhibitors |
CN1216050C (en) | 1998-10-23 | 2005-08-24 | 东丽株式会社 | 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same |
-
2000
- 2000-08-07 CA CA002382759A patent/CA2382759A1/en not_active Abandoned
- 2000-08-07 BR BR0012907-0A patent/BR0012907A/en not_active IP Right Cessation
- 2000-08-07 CN CN00813727A patent/CN1377263A/en active Pending
- 2000-08-07 AT AT00950027T patent/ATE306256T1/en not_active IP Right Cessation
- 2000-08-07 KR KR1020027001579A patent/KR20020016938A/en not_active Application Discontinuation
- 2000-08-07 US US10/048,952 patent/US7071359B1/en not_active Expired - Fee Related
- 2000-08-07 DE DE60023144T patent/DE60023144T2/en not_active Expired - Fee Related
- 2000-08-07 MX MXPA02001240A patent/MXPA02001240A/en unknown
- 2000-08-07 EP EP00950027A patent/EP1201235B1/en not_active Expired - Lifetime
- 2000-08-07 WO PCT/JP2000/005287 patent/WO2001010433A1/en active IP Right Grant
- 2000-08-07 AU AU63205/00A patent/AU782869B2/en not_active Ceased
-
2002
- 2002-06-14 HK HK02104447.9A patent/HK1042654B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA02001240A (en) | 2002-07-22 |
EP1201235A4 (en) | 2003-07-09 |
KR20020016938A (en) | 2002-03-06 |
EP1201235B1 (en) | 2005-10-12 |
US7071359B1 (en) | 2006-07-04 |
BR0012907A (en) | 2002-06-11 |
ATE306256T1 (en) | 2005-10-15 |
AU782869B2 (en) | 2005-09-08 |
DE60023144T2 (en) | 2006-07-06 |
HK1042654B (en) | 2006-01-06 |
EP1201235A1 (en) | 2002-05-02 |
DE60023144D1 (en) | 2006-02-23 |
CA2382759A1 (en) | 2001-02-15 |
CN1377263A (en) | 2002-10-30 |
AU6320500A (en) | 2001-03-05 |
WO2001010433A1 (en) | 2001-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2311742A1 (en) | 6-amino-9-benzyl-8-hydroxypurine derivatives | |
EP0775696A4 (en) | ||
PT976748E (en) | PIRROLIDINE DERIVATIVES WITH PHOSPHOLIPASE A2 INHIBITING ACTIVITY | |
EP1072263A4 (en) | Amide derivatives and nociceptin antagonists | |
IL135537A0 (en) | Substituted fused heterocyclic compounds | |
EP1184373A4 (en) | Tricyclic compounds | |
EP1243268A4 (en) | Medicinal composition | |
AU2001269540A1 (en) | Serotonin reuptake inhibitors | |
IL149213A0 (en) | Oxime o-ether compounds and fungicides for agricultural and horticultural use | |
EP0921122A4 (en) | Novel epoxysuccinamide derivatives or salts thereof | |
IL150965A0 (en) | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative | |
HK1042654A1 (en) | Neuropathy improvers containing nitrogenous compounds as the active ingredient | |
AU689808B2 (en) | Dithiocarbonimide derivative, fungicidal/insecticidal/ acaricidal agent containing said derivative as active ingredient, intermediate for use in production of said derivative and process for producing said derivative from said intermediate | |
AU2407697A (en) | 1-methylcarbapenem derivatives | |
AU2001228862A1 (en) | Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives | |
IL151880A0 (en) | Triazole derivatives and pharmaceutical compositions containing the same | |
DK1433480T3 (en) | Drug containing pyrimidine derivative | |
EG20464A (en) | Amidothiophosphate derivative and insecticide nematocide acaricide containing the same as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090807 |